BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verbrugge I, de Vries E, Tait SW, Wissink EH, Walczak H, Verheij M, Borst J. Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway. Oncogene 2008;27:574-84. [PMID: 17684487 DOI: 10.1038/sj.onc.1210696] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Mahami-Oskouei M, Norouzi B, Ahmadpour E, Kazemi T, Spotin A, Alizadeh Z, Ghorbani Sani R, Asadi M. Expression analysis of circulating miR-146a and miR-155 as novel biomarkers related to effective immune responses in human cystic echinococcosis. Microb Pathog 2021;157:104962. [PMID: 34022359 DOI: 10.1016/j.micpath.2021.104962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zerp SF, Bibi Z, Verbrugge I, Voest EE, Verheij M. Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system. Clin Transl Radiat Oncol 2020;24:1-9. [PMID: 32577539 DOI: 10.1016/j.ctro.2020.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yoshino H, Iwabuchi M, Kazama Y, Furukawa M, Kashiwakura I. Effects of retinoic acid-inducible gene-I-like receptors activations and ionizing radiation cotreatment on cytotoxicity against human non-small cell lung cancer in vitro. Oncol Lett 2018;15:4697-705. [PMID: 29541243 DOI: 10.3892/ol.2018.7867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
4 Ghorai A, Sarma A, Bhattacharyya NP, Ghosh U. Carbon ion beam triggers both caspase-dependent and caspase-independent pathway of apoptosis in HeLa and status of PARP-1 controls intensity of apoptosis. Apoptosis 2015;20:562-80. [PMID: 25670618 DOI: 10.1007/s10495-015-1107-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Alexiou GA, Tsamis KI, Vartholomatos E, Peponi E, Tzima E, Tasiou I, Lykoudis E, Tsekeris P, Kyritsis AP. Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. J Neurooncol 2015;123:217-24. [PMID: 25935110 DOI: 10.1007/s11060-015-1799-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
6 Zhang SB, Yang S, Vidyasagar S, Zhang M, Casey-Sawicki K, Liu C, Yin L, Zhang L, Cao Y, Tian Y, Swarts S, Fenton BM, Keng P, Zhang L, Okunieff P. PicoGreen assay of circular DNA for radiation biodosimetry. Radiat Res 2015;183:188-95. [PMID: 25574588 DOI: 10.1667/RR13556.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Alexiou GA, Tsamis KI, Kyritsis AP. Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas. Semin Pediatr Neurol 2015;22:35-9. [PMID: 25976259 DOI: 10.1016/j.spen.2014.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rooswinkel RW, van de Kooij B, de Vries E, Paauwe M, Braster R, Verheij M, Borst J. Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood 2014;123:2806-15. [PMID: 24622325 DOI: 10.1182/blood-2013-08-519470] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
9 Nayak RR, Bernal WE, Lee JW, Kearns MJ, Cheung VG. Stress-induced changes in gene interactions in human cells. Nucleic Acids Res 2014;42:1757-71. [PMID: 24170811 DOI: 10.1093/nar/gkt999] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
10 van de Kooij B, Rooswinkel RW, Kok F, Herrebout M, de Vries E, Paauwe M, Janssen GM, van Veelen PA, Borst J. Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B. Oncogene 2013;32:5439-48. [PMID: 23563182 DOI: 10.1038/onc.2013.99] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
11 van de Kooij B, Verbrugge I, de Vries E, Gijsen M, Montserrat V, Maas C, Neefjes J, Borst J. Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1. J Biol Chem 2013;288:6617-28. [PMID: 23300075 DOI: 10.1074/jbc.M112.448209] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
12 Niemoeller OM, Belka C. Radiotherapy and TRAIL for cancer therapy. Cancer Lett 2013;332:184-93. [PMID: 21824725 DOI: 10.1016/j.canlet.2011.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
13 Eisele G, Weller M. Targeting apoptosis pathways in glioblastoma. Cancer Lett 2013;332:335-45. [PMID: 21269762 DOI: 10.1016/j.canlet.2010.12.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
14 Cao X, Pobezinskaya YL, Morgan MJ, Liu ZG. The role of TRADD in TRAIL-induced apoptosis and signaling. FASEB J 2011;25:1353-8. [PMID: 21187341 DOI: 10.1096/fj.10-170480] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
15 Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, Chang GC, Chen JJ. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res. 2010;38:6148-6158. [PMID: 20494979 DOI: 10.1093/nar/gkq412] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
16 Weinlich R, Brunner T, Amarante-Mendes GP. Control of death receptor ligand activity by posttranslational modifications. Cell Mol Life Sci 2010;67:1631-42. [PMID: 20306114 DOI: 10.1007/s00018-010-0289-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
17 Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resistance Updates 2010;13:29-43. [DOI: 10.1016/j.drup.2010.01.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
18 Verbrugge I, Maas C, Heijkoop M, Verheij M, Borst J. Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Cell Death Differ 2010;17:551-61. [DOI: 10.1038/cdd.2009.141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
19 Corazza N, Kassahn D, Jakob S, Badmann A, Brunner T. TRAIL-induced apoptosis: between tumor therapy and immunopathology. Ann N Y Acad Sci 2009;1171:50-8. [PMID: 19723037 DOI: 10.1111/j.1749-6632.2009.04905.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
20 Marini P, Budach W, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions. Int J Radiat Oncol Biol Phys 2009;75:198-202. [PMID: 19695436 DOI: 10.1016/j.ijrobp.2009.04.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
21 Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. J Cell Physiol 2009;221:378-86. [PMID: 19562684 DOI: 10.1002/jcp.21863] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
22 Fakler M, Loeder S, Vogler M, Schneider K, Jeremias I, Debatin KM, Fulda S. Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance. Blood 2009;113:1710-22. [PMID: 19036706 DOI: 10.1182/blood-2007-09-114314] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 8.0] [Reference Citation Analysis]
23 Hayashi K, Motoyama S, Koyota S, Koizumi Y, Wang J, Takasawa S, Itaya-Hironaka A, Sakuramoto-Tsuchida S, Maruyama K, Saito H, Minamiya Y, Ogawa J, Sugiyama T. REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci 2008;99:2491-5. [PMID: 19032369 DOI: 10.1111/j.1349-7006.2008.00980.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
24 Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int J Radiat Oncol Biol Phys 2008;71:507-16. [PMID: 18474311 DOI: 10.1016/j.ijrobp.2008.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]